Financial Architects, Inc Bristol Myers Squibb CO Transaction History

Financial Architects, Inc

$657 Million
Q2 2023

A detailed history of Financial Architects, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Financial Architects, Inc holds 7,122 shares of BMY stock, worth $421,551. This represents 0.07% of its overall portfolio holdings.

Number of Shares

7,122

Previous 7,979 10.74%

Holding current value

$421,551

Previous $553,000 17.72%

% of portfolio

0.07%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $54,599 - $60,624	-857 Reduced 10.74%	7,122 $455,000
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $14,850 - $16,843	-226 Reduced 2.75%	7,979 $553,000
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $72,314 - $85,631	-1,056 Reduced 11.4%	8,205 $590,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $193 - $114,414	1,489 Added 19.16%	9,261 $658,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $8,641 - $9,517	119 Added 1.55%	7,772 $598,000
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $5,594 - $6,708	-91 Reduced 1.18%	7,653 $559,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $5,094 - $5,939	-95 Reduced 1.21%	7,744 $483,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $473 - $554	8 Added 0.1%	7,839 $464,000
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $6,748 - $7,348	109 Added 1.41%	7,831 $523,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $26,109 - $29,365	-440 Reduced 5.39%	7,722 $488,000
Q4 2020 Feb 17, 2021	BUY	$57.74 - $65.43 $461 - $523	8 Added 0.1%	8,162 $506,000
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $3,905 - $4,327	-68 Reduced 0.83%	8,154 $492,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $24,669 - $28,840	450 Added 5.79%	8,222 $483,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $6,217 - $9,035	-134 Reduced 1.69%	7,772 $433,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $46,109 - $60,146	937 Added 13.45%	7,906 $507,000
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $3,378 - $4,006	-79 Reduced 1.12%	6,969 $353,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $250,719 - $277,241	-5,619 Reduced 44.36%	7,048 $320,000
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $551,998 - $658,189	12,234 Added 2825.4%	12,667 $604,000
Q1 2019 May 03, 2019	SELL	$45.12 - $53.8 $450,026 - $536,601	-9,974 Reduced 95.84%	433 $21,000
Q4 2018 Feb 01, 2019	BUY	$48.76 - $63.23 $8,289 - $10,749	170 Added 1.66%	10,407 $541,000
Q3 2018 Oct 29, 2018	SELL	$55.19 - $62.25 $102,598 - $115,722	-1,859 Reduced 15.37%	10,237 $636,000
Q2 2018 Aug 03, 2018	BUY	$50.53 - $62.98 $35,118 - $43,771	695 Added 6.1%	12,096 $669,000
Q1 2018 Apr 23, 2018	SELL	$59.92 - $68.98 $131,164 - $150,997	-2,189 Reduced 16.11%	11,401 $721,000
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $279,919 - $305,184	-4,670 Reduced 25.58%	13,590 $833,000
Q3 2017 Nov 01, 2017	BUY	$55.23 - $63.74 $956,970 - $1.1 Million	17,327 Added 1857.13%	18,260 $1.16 Million
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $51,529 - $59,469	933	933 $59,000

Others Institutions Holding BMY

# of Institutions

2,765

Shares Held

1.56B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.

Account

Financial Architects, Inc Bristol Myers Squibb CO Transaction History